Medicalsystem Biotechnology Co.,Ltd.’s Net Profit Rose 19.7% in First Three Quarters of 2022

Medicalsystem Biotechnology Co.,Ltd. (美康生物科技股份有限公司) (300439.SZ) reported a net profit of 199.6 million yuan in the first three quarters of 2022, up 19.7% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 10.5% year-on-year.

At the end of the reporting period, it had 3.6 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 30.9%.